Aktuelle News

New Ovesco company building in the construction phase

Research & Development

Ovesco strengthens research on diagnostic devices with substantial funding The German Federal Ministry of Education
Header_FTRD_System

FTRD®: Multicenter Italian experience confirms effectiveness and safety of the FTRD for several high-risk indications in the colorectum

Technical success (lesion reached and resected) was achieved in 94.4 %. R0 resection was achieved
Ovesco Messestand

Conference of DGE-BV 2019 with FTRD® Lunch Symposium

Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) 2019 together with the
Header_OVE_Neubau_Solar2_2019-05-29_web

Ovesco Endoscopy AG setzt auf Solarkraft im Neubau

Nach dem Umzug in ihre neue Firmenzentrale im Technologiepark Tübingen Anfang Mai, nimmt die Ovesco
Header_News_OTSC_Gruppe

Systematic review and meta-analysis of OTSC® literature data covering 1868 patients confirms high technical and clinical success rates

Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 %
New Ovesco company building in the construction phase

ovesco Endoscopy AG zieht in neue Unternehmenszentrale

Die ovesco Endoscopy AG ist zum 29. April 2019 in ihre neue Unternehmenszentrale umgezogen und

Weitere News im Überblick

Ovesco is exhibitor at the APDW in Kolkata, India, December 12-15, 2019. We are looking
We are represented at the Endo-Update in Augsburg, November 28-29, 2019. It’s a great pleasure
We are represented at the United European Gastroenterology Week (UEGW) in Barcelona, Spain, October 19-23,
Ovesco is exhibitor at the 74th Annual Meeting of the German Society for Gastroenterology, Digestive
Ovesco is exhibitor at the NeuroGastro in Lisbon, Portugal, September 5-7, 2019. We are looking
Visit our booth at the Annual Meeting of the Swiss Society of Gastroenterology on the
Ovesco is exhibitor at the 24th International Federation for the Surgery of Obesity and Metabolic
Ovesco strengthens research on diagnostic devices with substantial funding The German Federal Ministry of Education
In lesions of 3 cm, EMR+ reaches its best discriminatory power: R0 resection rate of
Visit our booth at the 47th Annual Conference of Gastroenterology in Bavaria, June 27–28, 2019,
Technical success (lesion reached and resected) was achieved in 94.4 %. R0 resection was achieved
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) 2019 together with the
Nach dem Umzug in ihre neue Firmenzentrale im Technologiepark Tübingen Anfang Mai, nimmt die Ovesco
Visit our booth at the 7th Gastroenterology days in Ludwigshafen, May 24–25, 2019. We are
Ovesco is exhibitor at the 50<sup>th</sup> Digestive Disease Week in San Diego, California, May 18-21,
Visit our booth at Endoscopy live in Berlin, May 10–11, 2019. We are looking forward
Pooled durable clinical success proportions of OTSC use were 87.5 % in hemorrhage, 81.4 %
Die ovesco Endoscopy AG ist zum 29. April 2019 in ihre neue Unternehmenszentrale umgezogen und
Prospective data from 51 FTRD-procedures shows technical success in 88 % (45/51) and a R0-resection
Ovesco ist Aussteller auf der 49. DGE-BV in Stuttgart. Besuchen Sie uns vom 28. bis
Ovesco is proud to announce that both the OTSC® System and the remOVE System including
6 consecutive T1-ERC patients underwent FTRD application which resulted in complete endoscopic resection in all
EFTR of duodenal lesions in 20 patients showed technical success in 17/20 (85.0 %), a
96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower
Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success
Ovesco is exhibitor at the 21st Düsseldorf International Endoscopy Symposium, February 7 – 9, 2019.
Italian single-center study of 20 consecutive patients with non-lifting lesions, adenoma recurrence/relapse of previous endoscopic
Ovesco Endoscopy AG merges all business entities in the Americas into its Ovesco Endoscopy USA
Ovesco nimmt als Aussteller an der neuen Fortbildungsreihe „Interdisziplinäre Viszeralmedizinische Akademie“ (IVA 2019) im Münchener
OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical success rate of
Ovesco unterstützt das 8. Seminar „Endoskopie und Intervention in der Kindergastroenterologie“ in Mühlheim an der
Stuttgart, December 11, 2018 – Three medical technology companies of Tübingen receive the familyNET Award
OTSC use decreased the rebleeding rate in high-risk (RS ≥ 8) patients with statistical significance
Conference Report of the United European Gastroenterology Week (UEGW) 2018: RESECT+: additional working channel (AWC®)
All 19 patients were treated successfully with the OTSC System. In 74 % of cases,
Multicenter study shows high technical success rate and significant improvement of dysphagia symptoms. B Walter
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
100 % primary hemostasis rate and improved management of rebleeding with OTSC® used as first
Ovesco is exhibitor at the 26th United European Gastroenterology Week 2018, 20th to 24th of
87.9 % R0-resection of non-lifting and submucosal colonic lesions with FTRD® Aepli P et al.,
66.6 % of patients with leaking from the “J” of the tip of an ileo-anal
Ovesco is exhibitor at the SGG-SGVC-SASL Annual Congress 2018, 27th an 28th of September 2018
Dr Wedi received the DGVS endoscopy research award for the FLETRock study, a multi-centric study
Ovesco unterstützt den Interventionsworkshop Viszeralmedizin am St. Bernhard-Hospital in Kamp-Lintfort am Freitag, den 5. Oktober
Bauder M et al., Department of Gastroenterology and Oncology, Ludwigsburg Hospital, Ludwigsburg, Germany, presented a
Ovesco is exhibitor at the Viszeralmedizin 2018, 73. annual meeting of theDGVS with endoscopy section
Ovesco will offer a workshop at the 11th Endosummer on the 8th of September 2018,
A systematic literature review evaluating efficacy and safety of the OTSC System in the management
A systematic literature review evaluating efficacy and safety of the OTSC System in the management
Kobara H and colleagues, Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa,
Raithel M and colleagues, Department of Medicine II, University Erlangen, Germany presented data from three
As part of the “Tübinger Klimaschutzpakt” the Ovesco Endoscopy AG contributes to climate protection and
Ovesco is proud to announce that the OTSC® System including the OTSC® Anchor and the
Mizrahi I and colleagues, Digestive Disease Institute, Cleveland Clinic Florida, Weston, FL, USA, reported their
Honegger C and colleagues, Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland, presented
Ovesco is exhibitor at the annual meeting oft the „SW-Gesellschaft für Gastroenterologie“ on the 22nd
Gianfranco G. et al., Interventional Endoscopy Unit, Hospital Privé des Peupliers, Paris, France, presented a
Ovesco ist Aussteller bei der 46. Jahrestagung der Gesellschaft für Gastroenterologie in Bayern e.V. am
Ovesco is sponsor and exhibitor of the endoscopy workshop, which takes place on the 6th
OTSC has long been described in the scientific literature as a highly effective device for
Ovesco is exhibitor at the Digestive Disease Week 2018, 2nd to 5th of June, 2018
Valli and colleagues, Division of Gastroenterology and Hepatology, Zurich University Hospital, Switzerland, reported about their
Ovesco welcomes following new distribution partners: Biogene Pharma Limited, a leading distributor of Medical Device
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) together with the learned
Prof Dr Alexander Meining, Department of Interventional and Experimental Endoscopy, University Hospital Ulm, received the
Within the scope of the Annual Meeting of the Chilean – Germany Chamber of Commerce
A. Braun and H. Dawson, Gastroenterology and Endoscopy, SRO Langenthal, Switzerland and Institute of Pathology,
The 48th Conference of the German Society for Endoscopy and Imaging Procedures (Deutsche Gesellschaft für
El Douaihy Y et al., Department of Internal Medicine, Staten Island University Hospital – Northwell
Ovesco is sponsor of the 44th German „Koloproktologen-Kongress“ from 15th of March to 17th of
DGE-BV from 15th to 17th of March 2018 in Munich Thursday, March 15th, 2018 |
PD Dr Schmidt, Department of Inner Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectiology, University Hospital
J Brandler and colleagues, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, performed a
Ovesco exhibits at the 20th International Endoscopy Symposium in Düsseldorf, Germany, under the presidency of
Ovesco is proud to announce the launch of the BougieCap. A new method for the
Ovesco announces that the remOVE System has been cleared by the US Food and Drug
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
One of Germany’s first innovation awards, the state innovation award Baden-Württemberg – Dr.-Rudolf-Eberle-Prize – has
Veranstaltungsort Robert-Bosch-Krankenhaus Pavillon 3, Räume der Endoskopie Auerbachstraße 110, 70376 Stuttgart Programm
Ovesco is proud to announce that OTSC has received market approval in Peru. The product
Mangiafico S et al., Azienda Ospedaliero, University of Modena, Italy, presented at the 25th UEG
Chan SM and Lau JYW, Prince of Wales Hospital, The Chinese University of Hong Kong,
Ovesco ist Sponsor des EndoAkademie-Hands-on Trainingskurses zur endoskopisch interventionellen Koloskopie im Rahmen der DGVS Tagung
25th United European Gastroenterology Week 2017, 28th October to 1st November, 2017 in Barcelona, Spain
Ovesco is proud to announce that OTSC has received market approval in Taiwan. The product
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
Devan Kizhakee – new Commercial Director MEA, Australasia Devan Kizhakee Kurichyath has an extensive experience
SGG-SGVC-SASL Annual Congress 2017, 14 to 15 September, in Lausanne. Thursday, 14 September 2017 Friday,
EndoAkademie Hämostase Workshop im Rahmen der DGVS Tagung 2017 in Dresden. Hier können unterschiedlichste endoskopische
Veranstaltungsort Messe Dresden Messering 6 01067 Dresden Vorprogramm Informationen und Registrierung Kongresspräsident DGVS Prof. Dr.
In July Ovesco Endoscopy celebrated their groundbreaking ceremony for its new corporate headquarters for management,
Schmidt A, Beyna T, Schumacher B et al., affiliated to different German hospitals (Ludwigsburg, Freiburg,
Business news magazine brand eins rates Ovesco Endoscopy among the most innovative German companies. The
Ovesco Endoscopy rated as one of the most innovative German companies Business news magazine brand
Innovative BougieCap and resection method developed in cooperation with Ovesco, randomized controlled study shows significant
Tübingen, July 19, 2017 – Groundbreaking ceremony marks beginning of construction Das Tübinger Medizintechnikunternehmen errichtet
Ovesco publishes an updated OTSC® update containing further relevant publications on research conducted with the
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
Xiao X and Lau JY, Department of Surgery, Chinese University of Hong Kong, Hong Kong,
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
Within the scope of the Annual Meeting of the British Society for Gastroenterology (BSG) from
R Manta et al., Niguarda-Ca Granda Hospital, Milan, Nuovo S. Agostino Hospital, Modena, Nuovo Regina
Ovesco Endoscopy USA will be attending the 2017 ASCRS in Seattle, Washington from the 10th
Within the scope of the DGE-BV / Endoscopy Live Congress in Berlin, the afternoon symposium
Dr. Malay Sharma from North India received the audiovisual award for the use of the
Ovesco Endoscopy USA will be attending the 2017 DDW the 6th to the 9th of
Dr. Schmidt, Department of Inner Medicine, Gastroenterology, Hemato-Oncology, Diabetology and Infectiology, Ludwigsburg Hospital, Germany, received
The internet platform Endoscopy Campus is providing the latest information about endoscopy. Together with DGVS
Mittwoch, 05.04.2017 | 11:30 – 15:00 Donnerstag, 06.04.2017 | 08:30 – 18:00 Freitag, 07.04.2017 |
Bester Beitrag im Bereich „upper GI“, DGE-BV-Kongress 2017 Präsentation der Ergebnisse der prospektiv randomisiert-kontrollierten multizentrischen
Ovesco ist Sponsor des 43. Deutscher Koloproktologen-Kongresses vom 30.03. bis 01.04.2017 in München. Donnerstag, 30.03.2017
HJ Richter-Schrag and colleagues, Center of Interdisciplinary Gastrointestinal Endoscopy and Department of General and Visceral
Ovesco exhibits at the 19th International Endoscopy Symposium in Düsseldorf, Germany, under the presidency of
Ovesco ist Sponsor der 38. Schweizerische Koloproktologie-Tagung am 14.01.2017 in Bern. Samstag, 14.01.2017 | 8:00
Ovesco Endoscopy gehört zu den 3 innovativsten mittelständischen Unternehmen in Deutschland Der Deutsche Innovationspreis zeichnet
Bester Beitrag im Bereich „lower GI“, DGE-BV-Kongress 2016 „Endoskopische Vollwandresektion im Kolorektum mit dem FTRD:
Science for Life-Award von Olympus Europe und DGVS „Endoskopische Vollwandresektion im Kolorektum mit dem neuen
Bestes Poster, 12th Bionics Conference of the Society of Technical Biology and Bionics  “Optimierung eines
Preis für exzellenten Technologietransfer von CCI / IHK Reutlingen Erfolgreiches Transferprojekt und Kooperation mit regionalem
Preis für eine Präsentation beim SED-Kongress, Spanien “Report on a successful closure of a pharyngocutaneous
Bronzemedaille, Video World Cup, DDW-Kongress, USA Studie zur Resektion der unteren GI Läsionen mit Hilfe
Ovesco wins Award of the Ministry of Economics for successful product innovation and excellent economic
Award für die Präsentation der Studie im Bereich der Vollwandresektion von der DGE-BV Fallstudie zum
The VECTOR project receives „Best Exhibit Award“ on ICT 2010 conference in Brussels Link
OTSC use decreased the rebleeding rate in high-risk (RS ≥ 8) patients with statistical significance
Conference Report of the United European Gastroenterology Week (UEGW) 2018: RESECT+: additional working channel (AWC®)
All 19 patients were treated successfully with the OTSC System. In 74 % of cases,
Multicenter study shows high technical success rate and significant improvement of dysphagia symptoms. B Walter
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
100 % primary hemostasis rate and improved management of rebleeding with OTSC® used as first
87.9 % R0-resection of non-lifting and submucosal colonic lesions with FTRD® Aepli P et al.,
66.6 % of patients with leaking from the “J” of the tip of an ileo-anal
Dr Wedi received the DGVS endoscopy research award for the FLETRock study, a multi-centric study
Bauder M et al., Department of Gastroenterology and Oncology, Ludwigsburg Hospital, Ludwigsburg, Germany, presented a
A systematic literature review evaluating efficacy and safety of the OTSC System in the management
Kobara H and colleagues, Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa,
Raithel M and colleagues, Department of Medicine II, University Erlangen, Germany presented data from three
As part of the “Tübinger Klimaschutzpakt” the Ovesco Endoscopy AG contributes to climate protection and
Ovesco is proud to announce that the OTSC® System including the OTSC® Anchor and the
Mizrahi I and colleagues, Digestive Disease Institute, Cleveland Clinic Florida, Weston, FL, USA, reported their
Honegger C and colleagues, Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland, presented
Gianfranco G. et al., Interventional Endoscopy Unit, Hospital Privé des Peupliers, Paris, France, presented a
OTSC has long been described in the scientific literature as a highly effective device for
Valli and colleagues, Division of Gastroenterology and Hepatology, Zurich University Hospital, Switzerland, reported about their
Ovesco welcomes following new distribution partners: Biogene Pharma Limited, a leading distributor of Medical Device
Conference of the German Society for Endoscopy and Imaging Procedures (DGE-BV) together with the learned
Prof Dr Alexander Meining, Department of Interventional and Experimental Endoscopy, University Hospital Ulm, received the
Within the scope of the Annual Meeting of the Chilean – Germany Chamber of Commerce
A. Braun and H. Dawson, Gastroenterology and Endoscopy, SRO Langenthal, Switzerland and Institute of Pathology,
The 48th Conference of the German Society for Endoscopy and Imaging Procedures (Deutsche Gesellschaft für
El Douaihy Y et al., Department of Internal Medicine, Staten Island University Hospital – Northwell
PD Dr Schmidt, Department of Inner Medicine II, Gastroenterology, Hepatology, Endocrinology and Infectiology, University Hospital
J Brandler and colleagues, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, performed a
Ovesco is proud to announce the launch of the BougieCap. A new method for the
Ovesco announces that the remOVE System has been cleared by the US Food and Drug
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
One of Germany’s first innovation awards, the state innovation award Baden-Württemberg – Dr.-Rudolf-Eberle-Prize – has
Ovesco is proud to announce that OTSC has received market approval in Peru. The product
Mangiafico S et al., Azienda Ospedaliero, University of Modena, Italy, presented at the 25th UEG
Chan SM and Lau JYW, Prince of Wales Hospital, The Chinese University of Hong Kong,
Ovesco is proud to announce that OTSC has received market approval in Taiwan. The product
Conference of the German Society of Gastroenterology, and Digestive and Metabolic Diseases with Endoscopy Section
Devan Kizhakee – new Commercial Director MEA, Australasia Devan Kizhakee Kurichyath has an extensive experience
In July Ovesco Endoscopy celebrated their groundbreaking ceremony for its new corporate headquarters for management,
Schmidt A, Beyna T, Schumacher B et al., affiliated to different German hospitals (Ludwigsburg, Freiburg,
Business news magazine brand eins rates Ovesco Endoscopy among the most innovative German companies. The
Innovative BougieCap and resection method developed in cooperation with Ovesco, randomized controlled study shows significant
Tübingen, July 19, 2017 – Groundbreaking ceremony marks beginning of construction Das Tübinger Medizintechnikunternehmen errichtet
Ovesco publishes an updated OTSC® update containing further relevant publications on research conducted with the
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
Xiao X and Lau JY, Department of Surgery, Chinese University of Hong Kong, Hong Kong,
Ovesco is proud to announce that the FTRD System including FTRD Marking Probe and FTRD
Within the scope of the Annual Meeting of the British Society for Gastroenterology (BSG) from
R Manta et al., Niguarda-Ca Granda Hospital, Milan, Nuovo S. Agostino Hospital, Modena, Nuovo Regina
Within the scope of the DGE-BV / Endoscopy Live Congress in Berlin, the afternoon symposium
Dr. Malay Sharma from North India received the audiovisual award for the use of the
Dr. Schmidt, Department of Inner Medicine, Gastroenterology, Hemato-Oncology, Diabetology and Infectiology, Ludwigsburg Hospital, Germany, received
The internet platform Endoscopy Campus is providing the latest information about endoscopy. Together with DGVS
HJ Richter-Schrag and colleagues, Center of Interdisciplinary Gastrointestinal Endoscopy and Department of General and Visceral